Expert Perspective: Encouraging Research Developments in the Treatment of MPNs

Published on

Topics include: Treatment and Understanding

On location at an MPN town meeting in Aurora, Colorado, Dr. Naval Daver from The University of Texas MD Anderson Cancer Center, discussed the latest developments in the treatment of myeloproliferative neoplasms (MPNs). Dr. Daver provides an overview of the research being done to improve patients responses and the duration of response to treatment with JAK inhibitors, through combination therapies. He also goes on to explain other therapies being studied, including PI3 kinase inhibitor therapies, immunomodulatory therapies, as well as BCL-2 inhibitors.  Watch now to see a hopeful look at the future of MPN treatment.

Produced in partnership with the University of Colorado Anschutz Medical Campus. Sponsored by Incyte Corporation.

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

View more programs featuring and

Produced in association with

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on May 23, 2018